22476-74-0

Basic information

• Product Name: 3,3-DIMETHYLPIPERAZIN-2-ONE
• Synonyms: 3,3-dimethylpiperazin-2-one(SALTDATA: FREE)
• CAS NO: 22476-74-0
• Molecular Formula: C₆H₁₂N₂O
• Molecular Weight: 128.18
• Product Categories: pharmacetical
• Mol File: 22476-74-0.mol

Chemical Properties

• Melting Point: 134 °C
• Boiling Point: 275 °C at 760 mmHg
• Flash Point: 132.5 °C
• Appearance: /
• Density: 0.96 g/cm³
• Vapor Pressure: 0.00523mmHg at 25°C
• Refractive Index: 1.431
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 15.55±0.40(Predicted)
• CAS DataBase Reference: 3,3-DIMETHYLPIPERAZIN-2-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-DIMETHYLPIPERAZIN-2-ONE(22476-74-0)
• EPA Substance Registry System: 3,3-DIMETHYLPIPERAZIN-2-ONE(22476-74-0)

Safety Data

• Hazardous Substances Data: 22476-74-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3,3-DIMETHYLPIPERAZIN-2-ONE is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and reactivity. Its ability to form stable compounds with a wide range of other molecules makes it a valuable component in the development of new drugs.
Used in Agrochemical Industry:
In the agrochemical industry, 3,3-DIMETHYLPIPERAZIN-2-ONE is utilized as a key intermediate in the synthesis of various agrochemicals, including pesticides and herbicides. Its versatility in forming stable compounds with other molecules contributes to the development of effective and targeted agrochemical products.
Used in Organic Synthesis:
3,3-DIMETHYLPIPERAZIN-2-ONE serves as a reactive intermediate in organic synthesis, allowing for the formation of a variety of organic compounds with diverse applications. Its unique structure and reactivity make it a valuable component in the synthesis of complex organic molecules.
Used in Treatment of Neurological Disorders:
3,3-DIMETHYLPIPERAZIN-2-ONE has been studied for its potential use in the treatment of neurological disorders, owing to its ability to interact with specific receptors and pathways in the nervous system. Its potential therapeutic effects are currently under investigation, with the aim of developing new treatments for various neurological conditions.
Used as a Solvent:
In some applications, 3,3-DIMETHYLPIPERAZIN-2-ONE can be used as a solvent for various chemical reactions, particularly those involving the synthesis of pharmaceuticals and agrochemicals. Its ability to dissolve a wide range of compounds makes it a useful solvent in certain chemical processes.
Used as a Psychoactive Drug:
3,3-DIMETHYLPIPERAZIN-2-ONE has been identified as a psychoactive drug, with potential effects on the central nervous system. Its psychoactive properties are currently being studied to better understand its mechanism of action and potential therapeutic applications.
Used as a Branched-Chain Fatty Acid:
3,3-DIMETHYLPIPERAZIN-2-ONE can also be considered a branched-chain fatty acid, which may have implications for its use in various biological processes and interactions. Further research is needed to fully understand its role and potential applications in this context.

InChI:InChI=1/C6H12N2O/c1-6(2)5(9)7-3-4-8-6/h8H,3-4H2,1-2H3,(H,7,9)

Upstream product

• 600-00-0 ethyl 2-bromoisobutyrate 
• 64-17-5 ethanol 
• 107-15-3 ethylenediamine 
• 75-86-5 2-hydroxy-2-methylpropanenitrile 

Downstream Products

• 161459-57-0 4-(3-Hydroxy-propyl)-3,3-dimethyl-piperazin-2-one 
• 5435-12-1 1,4-dibenzyl-2,2-dimethylpiperazine 
• 84477-72-5 2,2-dimethylpiperazine 
• 626223-67-4 4-(2-chloroacetyl)-3,3-dimethylpiperazine-2-one 
• 1104383-06-3 tert-butyl 2,2-dimethyl-3-oxo-piperazine-1-carboxylate 
• 86290-99-5 3,3,4-trimethylpiperazin-2-one 
• 161459-63-8 C₃₅H₃₈N₂O₉ 
• 953391-65-6 3,3-dimethyl-1-[4-(methyloxy)-3-nitrophenyl]-2-piperazinone 
• 126458-10-4 1,4-dibenzyl-2,2-dimethyl-3-oxopiperazine 
• 86219-80-9 4-(4-chloro-benzyl)-3,3-dimethyl-piperazin-2-one 
• 22492-72-4 3,3-Dimethyl-4-(2-hydroxyethyl)-2-oxopiperazin 
• 1197332-76-5 {5-[4-(4-methoxy-benzyl)-2,2-dimethyl-piperazin-1-ylmethyl]-pyridin-2-yl}-carbamic acid tert-butyl ester 
• 1197332-75-4 5-[4-(4-methoxy-benzyl)-2,2-dimethyl-piperazin-1-ylmethyl]-pyridin-2-ylamine 
• 1197332-86-7 6-[4-(4-methoxy-benzyl)-3,3-dimethyl-piperazin-1-ylmethyl]-pyridin-3-ylamine 

Relevant articles and documents

BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION

The present invention relates to certain bis-heteroaryl compounds, pharmaceutical compositions containing them, and methods of using them, including methods for preventing, reversing, slowing, or inhibiting protein aggregation, and methods of treating diseases that are associated with protein aggregation, including neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, Lewy body disease, Parkinson's disease with dementia, fronto- temporal dementia, Huntington's Disease, amyotrophic lateral sclerosis, and multiple system atrophy, and cancer including melanoma.

NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK

The present invention is concerned with substituted oxazole derivatives that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant protein kinases implicated in a variety of human and animal diseases s

COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS

The present application provides novel optionally substituted fused pyridine and pyrimidine bicyclic compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating FAK and/or Src activity by administering a therapeutically effective amount of one or more of the compounds to a subject. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the FAK and/or Src pathway. Advantageously, these compounds perform as dual FAK and/or Src inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer.

UREA INHIBITORS OF MAP KINASES

Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.

DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS

The invention relates to compounds of Formula (I), wherein the substituens are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, N-oxide thereof; processes for the preparation thereof; to p

ARYL AND HETEROARYL SULPHONAMIDES AS GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONISTS

The present invention therefore provides compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) processes for their preparation, pharmaceutical compositions containing the same and to their use in the treatment of gastrointestinal and other disorders.

CRYSTALLINE BASE OF TRANS-1-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-3,3-DIMETHYLPIPERAZINE

Crystalline base of compound trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, processes for the preparation of purified free base or salts of this compound, pharmaceutical compositions comprising the base and medical use thereof, incl

PROCESS FOR MAKING TRANS-1-((1R, 3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-3, 3-DIMETHYLPIPERAZINE

Described is a method for making the trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine (formula I) and salts thereof and a similar method for making 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine (formula IX) and salt

TARTRATE AND MALATE SALTS OF TRANS-1-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-3,3-DIMETHYLPIPERAZINE

A tartrate and malate salt of trans-1-(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine, in particular for medical use, pharmaceutical formulations thereof, including for treatment of schizophrenia or other diseases involving psychotic symptoms.

SUCCINATE AND MALONATE SALT OF TRANS-4-(IR,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE AND THE USE AS A MEDICAMENT

4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine hydrogen succinate or hadrogen malonat, pharmaceutical compositions containing these salts and the medical use thereof, including for the treatment of schizophrenia and other psychotic diso